Table 1 The summary of clinical information for 21 Chinese HCC patients
From: HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
Patient | Recurrent with 24 months± | Sex | Age | Primary tumor grade | Child | BCLC | Primary tumor size (cm) | Criteria (Milan = 1; UCSF = 2; Exceed = 3) | AFP (ng/mL) | MELD | Time of recurrent after OLT (month) | Recurrent tumor organ | HBV (pre-OLT) | HBV (post-OLT) | MULT± | SAT± | ENCAP± | CIRR± | VES± | THROMB± |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC1* | 1 | M | 48 | III | A | A3 | 5*5*3 | 1 | 2935.9 | 8 | 8 | Liver | Positive | Negative | 0 | 0 | 0 | 1 | 0 | 1 |
HCC4* | 1 | M | 59 | II | A | B | 8*6*5.5 | 3 | 2.5 | 5 | 6.5 | Liver | Positive | Positive | 1 | 1 | 1 | 0 | 0 | 0 |
HCC5* | 1 | M | 67 | II | A | B | 5*4*3 | 1 | >3000 | 2 | 18 | Liver | Negative | Negative | 1 | 0 | 0 | 1 | 0 | 1 |
HCC11* | 1 | F | 57 | II–III | A | B | 0.5–2.5 | 1 | 1581.6 | 2 | 16 | Lung | Negative | Negative | 1 | 0 | 0 | 1 | 0 | 0 |
HCC2 | 1 | M | 43 | II | A | B | 9*8*6 | 3 | 1461.1 | 21 | 19 | Liver | Positive | Negative | 0 | 1 | N/A | 1 | 0 | 0 |
HCC3 | 1 | M | 42 | III | B | B | 6*6*2.5, 10*8*4 | 3 | >3000 | 5 | 14.5 | Liver | Positive | Negative | 1 | 0 | 0 | 1 | 0 | 1 |
HCC6 | 1 | M | 41 | III | A | B | 7*5*4 | 3 | 126 | 4 | 1.5 | Lung | Positive | Negative | 0 | 0 | 0 | 1 | 0 | 0 |
HCC8 | 1 | M | 42 | III | A | B | 10*10*7 | 3 | >3000 | 5 | 11 | Liver | Positive | Negative | 0 | 1 | 0 | 1 | N/A | 1 |
HCC10 | 1 | M | 59 | III | A | A3 | 4*3.5*3.5 | 1 | 1888.2 | 15 | 6 | Liver | Positive | Negative | 0 | 0 | 0 | 1 | 0 | 1 |
HCC-C2 | 0 | M | 55 | I–II | C | D | 5.5*5*4.5* | 2 | 5.2 | 4 | N/A | N/A | Positive | Negative | 0 | 0 | 0 | 1 | 0 | 0 |
HCC-C6 | 0 | M | 51 | II | B | A3 | 3*2.5*2* | 1 | 137.5 | 13 | N/A | N/A | Positive | Negative | 0 | 0 | 0 | 1 | 0 | 0 |
HCC-C8 | 0 | M | 64 | I | B | A3 | 5*1.5*1.5*, 3*2*2* | 3 | 62.5 | 13 | N/A | N/A | Positive | Positive | 1 | 0 | 0 | 1 | 0 | 0 |
HCC-C9 | 0 | M | 40 | II | B | A3 | 1*1*1* | 1 | 9.2 | 3 | N/A | N/A | Positive | N/A | 0 | 0 | 0 | 1 | 0 | 0 |
HCC-C11 | 0 | M | 62 | I | A | A3 | 3*3*2* | 1 | 5.4 | 9 | N/A | N/A | Positive | Negative | 0 | 0 | 0 | 1 | 0 | 0 |
HCC-C12 | 0 | M | 40 | II–III | A | A2 | 2.5*1.5*1* | 1 | 210.8 | 4 | N/A | N/A | Positive | Positive | 0 | 0 | 0 | 1 | 0 | 0 |
HCC-C13 | 0 | M | 49 | I–II | A | C | 3*2.5*2.5*; 2*2*2* | 1 | 4.3 | 4 | N/A | N/A | Positive | Negative | 1 | 0 | 0 | 1 | 1 | 0 |
HCC-C14 | 0 | M | 59 | II | B | B | 7*5*5* | 3 | 240.7 | 20 | N/A | N/A | Positive | N/A | 0 | 0 | 0 | 1 | 0 | 0 |
HCC-C15 | 0 | M | 49 | II | A | B | 5*4*2*; 5*4.5*3* | 3 | NA | 4 | N/A | N/A | Positive | Negative | 0 | 1 | 0 | 1 | 0 | 0 |
HCC-C16 | 0 | M | 49 | II–III | B | A3 | 5*5*4* | 1 | 128.9 | 11 | N/A | N/A | Positive | N/A | 0 | 1 | 0 | 1 | 0 | 0 |
HCC-C18 | 0 | M | 57 | I | A | A2 | 5*4*4* | 1 | 6.6 | 2 | N/A | N/A | Positive | Negative | 0 | 0 | 0 | 1 | 0 | 0 |
HCC-C19 | 0 | M | 41 | II–III | A | B | 4*2.5*2*, 3*2*1.8* | 2 | 220.9 | 2 | N/A | N/A | Positive | Positive | 1 | 0 | 0 | 1 | 0 | 0 |